Search results

  1. COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response (NG169)

    The purpose of this guideline is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.

  2. COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response (NG172)

    The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID 19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.

  3. The percentage of patients with one or more of the following conditions: CHD, atrial fibrillation, chronic heart failure, stroke or TIA, diabetes or dementia with a FAST score of 3 or more or AUDIT-C score of 5 or more in the preceding 2 years who have received brief intervention to help them reduce their alcohol related risk within 3 months of the score being recorded

    The percentage of patients with one or more of the following conditions: CHD, atrial fibrillation, chronic heart failure, stroke or TIA, diabetes or...

  4. COVID-19 rapid guideline: managing COVID-19 (NG191)

    This guideline covers the management of COVID-19 for children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19 so that healthcare staff and those planning and delivering services can find and use them more easily. The guideline includes new recommendations on therapeutics, and we will update the guideline further as new evidence emerges.

  5. Low back pain and sciatica

    Everything NICE has said on low back pain and sciatica in an interactive flowchart

  6. Rheumatoid arthritis

    Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart

  7. Neuropathic pain

    Everything NICE has said on pharmacological management of neuropathic pain in adults in non-specialist settings in an interactive flowchart

  8. Patient experience in adult NHS services

    Everything NICE has said on improving the experience of care for people using adult NHS services in an interactive flowchart

  9. Chronic pain (primary and secondary)

    Everything NICE has said on assessing all chronic pain and managing chronic primary pain in people aged 16 years and over in an interactive flowchart.

  10. Endometriosis

    Everything NICE has said on diagnosing and managing endometriosis in an interactive flowchart

  11. Spondyloarthritis

    Everything NICE has said on diagnosing and managing spondyloarthritis in people aged 16 and over in an interactive flowchart

  12. Osteoarthritis

    Everything NICE has said on the care and management of osteoarthritis in adults in an interactive flowchart

  13. Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain (NG193)

    This guideline covers assessing all chronic pain (chronic primary pain, chronic secondary pain, or both) and managing chronic primary pain in people aged 16 years and over. Chronic primary pain is pain with no clear underlying cause, or pain (or its impact) that is out of proportion to any observable injury or disease.

  14. Liver cancers

    Everything NICE has said on liver and bile duct cancers in an interactive flowchart

  15. Heavy menstrual bleeding

    Everything NICE has said on assessing and managing heavy menstrual bleeding in an interactive flowchart

  16. Advanced breast cancer

    Everything NICE has said on diagnosing and treating advanced breast cancer in an interactive flowchart

  17. Alcohol-use disorders

    Everything NICE has said on preventing, diagnosing and managing alcohol-related disorders in an interactive flowchart

  18. Diabetes in pregnancy

    Everything NICE has said on managing diabetes and its complications before, during and after pregnancy in an interactive flowchart

  19. Caesarean birth

    Everything NICE has said on caesarean birth in an interactive flowchart

  20. Induction of labour

    Everything NICE has said on inducing labour in an interactive flowchart

  21. Intrapartum care

    Everything NICE has said on the care of healthy women and their babies during childbirth in an interactive flowchart

  22. Hypertension in pregnancy

    Everything NICE has said on diagnosing and managing hypertension in pregnancy in an interactive flowchart

  23. Urogenital conditions

    Everything NICE has said on urogenital conditions in an interactive flowchart

  24. Blood and bone marrow cancers

    Everything NICE has said on blood and bone marrow cancers including leukaemia in an interactive flowchart

  25. Preterm labour and birth

    Everything NICE has said on the care of women in or at risk of preterm labour or having a planned preterm birth in an interactive flowchart

  26. Musculoskeletal conditions

    Everything NICE has said on musculoskeletal conditions in an interactive flowchart

  27. Acute upper gastrointestinal bleeding

    Everything NICE has said on risk assessment and management of acute upper gastrointestinal bleeding in people 16 years and older in an interactive flowchart

  28. Liver conditions

    Everything NICE has said on liver conditions in an interactive flowchart

  29. Caesarean birth (QS32)

    This quality standard covers the care of women who are considering having or may need to have a caesarean birth, including those who have had a caesarean birth in the past. It includes decision making, reducing the risk of complications and care after a caesarean birth. It describes high-quality care in priority areas for improvement.

  30. Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy (TA687)

    Evidence-based recommendations on ribociclib (Kisqali) for treating hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally

  31. Selective internal radiation therapies for treating hepatocellular carcinoma (TA688)

    Evidence-based recommendations on selective internal radiation therapies SIR-Spheres (Sirtex), TheraSphere (BTG) and QuiremSphere (Quirem Medical) for treating

  32. Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids (IPG689)

    Evidence-based recommendations on transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids in adults. This involves inserting a

  33. Caesarean birth (NG192)

    This guideline covers when to offer caesarean birth, discussion of caesarean birth, procedural aspects of the operation, and care after caesarean birth. It aims to improve the consistency and quality of care for women who are thinking about having a caesarean birth or have had a previous caesarean birth and are pregnant again.

  34. Irritable bowel syndrome in adults

    Everything NICE has said on diagnosing and managing irritable bowel syndrome in adults in primary care in an interactive flowchart

  35. Headaches

    Everything NICE has said on the most common primary headache disorders in young people aged 12 years and older and adults in an interactive flowchart

  36. Multimorbidity

    Everything NICE has said on optimising care for people with 2 or more long-term health conditions in an interactive flowchart